Below are top highlights for May 2014: (Please click on read more to see details)
- Cipla of India makes $21 Mn investment in US-based Chase Pharma Read more
- India based Jubilant Pharma to enable better access to afforable medicines with IFC's $147.5 mn investment package Read more
- Connexios, India's first drug-discovery product startup signs out-licensing deal with Boehringer Ingelheim for its set of anti-diabetes molecules Read more
- India's Shasun acquires global rights for Ibuprofen OTC from ScolrPharma, USA Read more
- US Company Cancer Genetics Inc. buys Indian arm of genomics firm BioServe for $1.9 million Read more
- Royalty based Alliance between Finland's Orion Corp & India's Jubilant in neuroscience therapeutic area Read more
- India based Perfint Healthcare gets US FDA approval for marketing image-guided oncology device
- US based Akers Bioscience signs Agreement to Market Rapid Tests in India Read more
- BioPharma International "India's Developing Market Offers Opportunity - Biopharma companies should not overlook India's growing market."
For more such news and updates on Global Life Science Business in India please join this group at LinkedIn
Aagami Updates: (Please click on hyperlink to view details)
- Bio 2014 in San Diego - Aagami CEO Dinesh Jain representing several clients
- Aagami's Strategic Consulting Case Studies and Research Services Case Studiesare now available on its company website in 'Case Studies' Tab.